Viewing Study NCT04462406


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2026-01-03 @ 5:53 PM
Study NCT ID: NCT04462406
Status: RECRUITING
Last Update Posted: 2025-11-13
First Post: 2020-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: EA6192
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View